Return to homepagePandemic Pact

Clinical phenotyping to enable targeted treatment of persistent cognitive symptoms after COVID-19

Grant number: COV/LTE/20/26

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $398,589.17

  • Funder

    CSO Scotland

  • Principal Investigator

    Prof. Alan Carson

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Edinburgh

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

People with 'Long Covid' describe memory and concentration problems. Studies examining how people perform on memory and intelligence tests have found that patients who have had COVID-19 perform worse than those who have not. But to date, we don't know why they have poorer cognitive function. Memory and concentration symptoms in 'Long Covid' are likely to have different causes in different people. Some may have had direct infection or inflammation of the brain, or blockages to blood vessels in the brain. In others, underlying brain disease may have been 'unmasked' by COVID-19. Some may have functional cognitive disorders, where memory and concentration problems are the result of changes in the brain's 'software'. In others, anxiety, low mood or fatigue may contribute to their symptoms. Each of these conditions has a different outcome and treatment. This study aims to closely examine 100 people with persisting cognitive symptoms after COVID-19, assessing the cognitive problems as well as markers of brain damage, inflammation, and underlying degenerative brain disease.